National HealthCare Corporation (NHC)
NYSEAMERICAN: NHC · IEX Real-Time Price · USD
91.47
-1.94 (-2.08%)
May 3, 2024, 4:00 PM EDT - Market closed

National HealthCare Revenue

In the year 2023, National HealthCare had annual revenue of $1.14B with 5.14% growth. Revenue in the quarter ending December 31, 2023 was $300.91M with 13.74% year-over-year growth.

Revenue (ttm)
$1.14B
Revenue Growth
+5.14%
P/S Ratio
1.23
Revenue / Employee
$86,988
Employees
13,123
Market Cap
1.40B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.14B55.81M5.14%
Dec 31, 20221.09B11.44M1.06%
Dec 31, 20211.07B46.09M4.48%
Dec 31, 20201.03B31.83M3.19%
Dec 31, 2019996.38M16.03M1.64%
Dec 31, 2018980.35M16.45M1.71%
Dec 31, 2017963.90M40.32M4.37%
Dec 31, 2016923.58M16.96M1.87%
Dec 31, 2015906.62M34.94M4.01%
Dec 31, 2014871.68M82.73M10.49%
Dec 31, 2013788.96M27.96M3.67%
Dec 31, 2012761.00M-12.24M-1.58%
Dec 31, 2011773.24M52.59M7.30%
Dec 31, 2010720.65M47.45M7.05%
Dec 31, 2009673.20M39.99M6.32%
Dec 31, 2008633.21M53.85M9.29%
Dec 31, 2007579.36M16.40M2.91%
Dec 31, 2006562.96M20.58M3.79%
Dec 31, 2005542.38M20.55M3.94%
Dec 31, 2004521.83M48.97M10.35%
Dec 31, 2003472.86M14.61M3.19%
Dec 31, 2002458.25M38.29M9.12%
Dec 31, 2001419.97M-42.45M-9.18%
Dec 31, 2000462.42M22.27M5.06%
Dec 31, 1999440.15M-1.07M-0.24%
Dec 31, 1998441.21M-22.26M-4.80%
Dec 31, 1997463.48M77.21M19.99%
Dec 31, 1996386.27M36.87M10.55%
Dec 31, 1995349.40M50.50M16.89%
Dec 31, 1994298.90M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.20B
Agiliti 1.17B
Warby Parker 669.77M
ANI Pharmaceuticals 486.82M
InMode 466.26M
Kiniksa Pharmaceuticals 301.77M
Xencor 168.34M
Arcus Biosciences 117.00M
Revenue Rankings